The Research and Development Team at enGene Inc. focuses on advancing the proprietary non-viral gene therapy platform by designing and conducting experiments to optimize the delivery of various nucleic acid payloads to mucosal tissues. The team members work collaboratively on the innovation and application of the DDX platform, aiming to achieve therapeutic breakthroughs for a broad range of diseases.